Gene-Editing Breakthrough Expands Cancer Treatment Beyond Current Drug Limits

CRISPR technology now demonstrates the ability to selectively target 'undruggable' cancers—tumors that conventional pharmaceuticals cannot effectively treat. This advancement significantly expands the therapeutic potential of gene therapy, opening treatment pathways for cancer types previously considered difficult or impossible to address with traditional drugs. The selective precision of the technique suggests improvements in treatment efficacy while potentially reducing side effects.